Glaucoma

Preserved glaucoma product use increases the probability that future glaucoma surgery will fail. Let’s examine the literature…

For doctors and other operators to get familiar with the Widefield Imaging Module, the Heidelberg Engineering Academy has recently launched an interactive video tutorial.

Taking the time to talk with patients about the signs and symptoms of ocular surface disease and performing some quick assessments could ensure selection of the most appropriate therapy, and help improve patient outcomes

“Smart” nanowires deliver drugs on demand using an applied electromagnetic field

Why persist with preservatives? Those present in topical glaucoma therapies don’t improve the active compound’s efficacy – and cause ocular surface disease in many patients

A light box and a 35 mm slide could be all you need for therapeutic laser target practice

Thermography could offer a noninvasive way of assessing bleb function

VR headsets could identify those with glaucoma at the greatest risk of falls

As many as six in every ten patients with glaucoma have ocular surface disease – and this can have a huge impact on their daily lives. We explore why, and what can be done.

Trimming down the number of concomitant topical glaucoma medications your patients need with MIGS devices could lead to happier patients with better-controlled IOP.